Clinical Pharmacology of GW280430A in Humans

Anesthesiology

Volumn 100, Issue 4, 2004, Pages 768-773

  Belmont, Matthew R ^a,d   Lien, Cynthia A ^a   Tjan, Joseph ^a   Bradley, Eleanor ^b   Stein, Brenna ^b   Patel, Sanjay S ^c   Savarese, John J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Clinical Research   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; GW 280430A; MIDAZOLAM; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; HISTAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR TRANSMISSION; NORMAL HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; ULNAR NERVE;

ADOLESCENT; ADULT; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HISTAMINE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SUCCINYLCHOLINE;

EID: 1642392352     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200404000-00004     Document Type: Article

References (12)

1. Savarese JJ, Kitz RJ: Does clinical anesthesia need new neuromuscular blocking agents? ANESTHESIOLOGY 1975; 42:236-9
2. Belmont MR: Succinylcholine/suxamethonium. Curr Opin Anesthesiol 1995; 8:362-6
3. Mahajan RP: Is suxamethonium now obsolete? Curr Anaesth Crit Care 1996; 7:289-94
4. Savarese JJ, Belmont MR, Hashim MA, Mook RA Jr, Boros EE, Samano V, Patel SS, Feldman PL, Schultz J-AI, McNulty M, Spitzer T, Cohn DI., Morgan P, Wastila WB: Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: A comparison with mivacurium. ANESTHESIOLOGY 2003; 100:000-000
5. Heerdt P, Kang R, The A, Hashim M, Mook R, Savarese, J: Cardiopulmonary effects of the novel neuromuscular blocking drug GW280430A in dogs. ANESTHESIOLOGY 2003; 100:000-000
6. Kahwaji R, Bevan D, Bikhazi G, Shanks C, Fragen R, Dyck J, Angst M, Matteo R: Dose-ranging study in younger adult and elderly patients of Org 9487, a new, rapid-onset, short-duration muscle relaxant. Anesth Analg 1997; 84:1011-8
7. Savarese J, Ali H, Basta S, Embree P, Scott R, Sander N, Weakley J, Wastila W, El-Sayad H: The clinical neuromuscular pharmacology of mivacurium chloride (BW1090U). ANESTHESIOLOGY 1988; 68:723-32
8. Belmont MR, Lien CA, Savarese JJ: Neuromuscular blocking properties of rapacuronium at the adductor pollicis and larynx. ANESTHESIOLOGY 2001; 95:A998
9. Levy J, Pitts M, Thanopoulos A, Szlam F, Bastian R, Kim J: The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia. Anesth Analg 1999; 89:290-5
10. Van den Broek L, Wierda J, Smeulers N, Proost J: Pharmacodynamics and pharmacokinetics of an infusion of Org 9847, a new short-acting steroidal neuromuscular blocking agent. Br J Anaesth 1994; 73:331-5
11. Szenohradszky J, Caldwell J, Wright P, Brown R, Lau M, Luks A, Fisher D: Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide. ANESTHESIOLOGY 1999; 90:24-35
12. Belmont MR, Lien C, Quessy S, Abou-Donia M, Abalos A, Eppich L, Savarese J: The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. ANESTHESIOLOGY 1995; 82:1139-45